These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33594533)

  • 1. The PDE10A Inhibitor TAK-063 Reverses Sound-Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome.
    Jonak CR; Sandhu MS; Assad SA; Barbosa JA; Makhija M; Binder DK
    Neurotherapeutics; 2021 Apr; 18(2):1175-1187. PubMed ID: 33594533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic analysis of multielectrode array EEG biomarkers in developing and adult male Fmr1 KO mice.
    Jonak CR; Assad SA; Garcia TA; Sandhu MS; Rumschlag JA; Razak KA; Binder DK
    Neurobiol Dis; 2024 Jun; 195():106496. PubMed ID: 38582333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome.
    Lovelace JW; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2018 Jul; 115():39-48. PubMed ID: 29605426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multielectrode array analysis of EEG biomarkers in a mouse model of Fragile X Syndrome.
    Jonak CR; Lovelace JW; Ethell IM; Razak KA; Binder DK
    Neurobiol Dis; 2020 May; 138():104794. PubMed ID: 32036032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of Fmr1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular, EEG, and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome.
    Lovelace JW; Rais M; Palacios AR; Shuai XS; Bishay S; Popa O; Pirbhoy PS; Binder DK; Nelson DL; Ethell IM; Razak KA
    Cereb Cortex; 2020 Mar; 30(3):969-988. PubMed ID: 31364704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma power abnormalities in a Fmr1-targeted transgenic rat model of fragile X syndrome.
    Kozono N; Okamura A; Honda S; Matsumoto M; Mihara T
    Sci Rep; 2020 Nov; 10(1):18799. PubMed ID: 33139785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baclofen-associated neurophysiologic target engagement across species in fragile X syndrome.
    Jonak CR; Pedapati EV; Schmitt LM; Assad SA; Sandhu MS; DeStefano L; Ethridge L; Razak KA; Sweeney JA; Binder DK; Erickson CA
    J Neurodev Disord; 2022 Sep; 14(1):52. PubMed ID: 36167501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute pharmacological inhibition of matrix metalloproteinase-9 activity during development restores perineuronal net formation and normalizes auditory processing in Fmr1 KO mice.
    Pirbhoy PS; Rais M; Lovelace JW; Woodard W; Razak KA; Binder DK; Ethell IM
    J Neurochem; 2020 Dec; 155(5):538-558. PubMed ID: 32374912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental Changes in EEG Phenotypes in a Mouse Model of Fragile X Syndrome.
    Wen TH; Lovelace JW; Ethell IM; Binder DK; Razak KA
    Neuroscience; 2019 Feb; 398():126-143. PubMed ID: 30528856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome.
    Ethridge LE; White SP; Mosconi MW; Wang J; Pedapati EV; Erickson CA; Byerly MJ; Sweeney JA
    Mol Autism; 2017; 8():22. PubMed ID: 28596820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline Treatment Reverses Sound Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome.
    Lovelace JW; Ethell IM; Binder DK; Razak KA
    Front Neurosci; 2020; 14():771. PubMed ID: 32848552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the
    Sinclair D; Featherstone R; Naschek M; Nam J; Du A; Wright S; Pance K; Melnychenko O; Weger R; Akuzawa S; Matsumoto M; Siegel SJ
    eNeuro; 2017; 4(1):. PubMed ID: 28451631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased 2-arachidonoyl-sn-glycerol levels normalize cortical responses to sound and improve behaviors in Fmr1 KO mice.
    Pirbhoy PS; Jonak CR; Syed R; Argueta DA; Perez PA; Wiley MB; Hessamian K; Lovelace JW; Razak KA; DiPatrizio NV; Ethell IM; Binder DK
    J Neurodev Disord; 2021 Oct; 13(1):47. PubMed ID: 34645383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
    Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA
    Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons.
    Holley AJ; Shedd A; Boggs A; Lovelace J; Erickson C; Gross C; Jankovic M; Razak K; Huber K; Gibson JR
    Neurobiol Dis; 2022 Aug; 170():105767. PubMed ID: 35588990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
    Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
    Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational Development Strategies for TAK-063, a Phosphodiesterase 10A Inhibitor.
    Macek TA; Suzuki K; Asin K; Kimura H
    Int J Neuropsychopharmacol; 2020 Nov; 23(8):524-532. PubMed ID: 32598478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo pharmacological characterization of TAK-063, a potent and selective phosphodiesterase 10A inhibitor with antipsychotic-like activity in rodents.
    Suzuki K; Harada A; Shiraishi E; Kimura H
    J Pharmacol Exp Ther; 2015 Mar; 352(3):471-9. PubMed ID: 25525190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexually dimorphic patterns in electroencephalography power spectrum and autism-related behaviors in a rat model of fragile X syndrome.
    Wong H; Hooper AWM; Niibori Y; Lee SJ; Hategan LA; Zhang L; Karumuthil-Melethil S; Till SM; Kind PC; Danos O; Bruder JT; Hampson DR
    Neurobiol Dis; 2020 Dec; 146():105118. PubMed ID: 33031903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.